Tompkins Financial Corp Sells 901 Shares of Kimberly-Clark Co. (NYSE:KMB)

Tompkins Financial Corp lowered its holdings in shares of Kimberly-Clark Co. (NYSE:KMB) by 2.2% in the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 40,987 shares of the company’s stock after selling 901 shares during the quarter. Tompkins Financial Corp’s holdings in Kimberly-Clark were worth $5,659,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors and hedge funds have also made changes to their positions in KMB. Sciencast Management LP increased its stake in Kimberly-Clark by 44.7% during the second quarter. Sciencast Management LP now owns 8,460 shares of the company’s stock worth $1,150,000 after acquiring an additional 2,615 shares during the last quarter. Contravisory Investment Management Inc. increased its position in shares of Kimberly-Clark by 2.6% during the 2nd quarter. Contravisory Investment Management Inc. now owns 44,932 shares of the company’s stock valued at $6,203,000 after purchasing an additional 1,128 shares during the last quarter. Platform Technology Partners raised its holdings in Kimberly-Clark by 3.0% during the 2nd quarter. Platform Technology Partners now owns 5,922 shares of the company’s stock valued at $801,000 after buying an additional 175 shares during the period. First Bank & Trust lifted its position in Kimberly-Clark by 12.3% in the second quarter. First Bank & Trust now owns 18,189 shares of the company’s stock worth $2,511,000 after buying an additional 1,999 shares during the last quarter. Finally, Ignite Planners LLC purchased a new position in Kimberly-Clark during the second quarter worth $210,000. 74.38% of the stock is owned by hedge funds and other institutional investors.

Kimberly-Clark Stock Down 0.9 %

Shares of NYSE KMB traded down $1.08 during midday trading on Tuesday, reaching $124.04. 136,218 shares of the company’s stock traded hands, compared to its average volume of 1,683,127. The company has a market cap of $41.95 billion, a price-to-earnings ratio of 25.80, a P/E/G ratio of 2.38 and a beta of 0.39. The stock’s 50 day simple moving average is $129.65 and its 200-day simple moving average is $133.88. The company has a quick ratio of 0.55, a current ratio of 0.87 and a debt-to-equity ratio of 12.21. Kimberly-Clark Co. has a one year low of $108.74 and a one year high of $147.87.

Kimberly-Clark (NYSE:KMB) last released its quarterly earnings results on Tuesday, July 25th. The company reported $1.65 earnings per share for the quarter, beating analysts’ consensus estimates of $1.48 by $0.17. Kimberly-Clark had a net margin of 8.07% and a return on equity of 303.40%. The business had revenue of $5.13 billion for the quarter, compared to analysts’ expectations of $5.13 billion. The company’s revenue was up 1.4% compared to the same quarter last year. During the same period last year, the business earned $1.34 EPS. On average, analysts predict that Kimberly-Clark Co. will post 6.42 EPS for the current fiscal year.

Kimberly-Clark Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, October 3rd. Stockholders of record on Friday, September 8th will be given a $1.18 dividend. The ex-dividend date is Thursday, September 7th. This represents a $4.72 dividend on an annualized basis and a dividend yield of 3.81%. Kimberly-Clark’s payout ratio is 97.32%.

Insider Buying and Selling

In other news, insider Sandra R. Karrmann sold 5,122 shares of the business’s stock in a transaction dated Tuesday, August 29th. The stock was sold at an average price of $129.80, for a total transaction of $664,835.60. Following the sale, the insider now owns 6,228 shares in the company, valued at $808,394.40. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. In related news, insider Jeffrey P. Melucci sold 4,423 shares of the firm’s stock in a transaction on Thursday, July 27th. The stock was sold at an average price of $130.23, for a total value of $576,007.29. Following the completion of the transaction, the insider now owns 28,169 shares in the company, valued at approximately $3,668,448.87. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Sandra R. Karrmann sold 5,122 shares of the business’s stock in a transaction dated Tuesday, August 29th. The shares were sold at an average price of $129.80, for a total value of $664,835.60. Following the sale, the insider now owns 6,228 shares in the company, valued at approximately $808,394.40. The disclosure for this sale can be found here. 0.67% of the stock is owned by company insiders.

Wall Street Analyst Weigh In

Several equities research analysts have recently weighed in on KMB shares. Bank of America reduced their target price on shares of Kimberly-Clark from $145.00 to $138.00 in a research note on Wednesday, July 26th. Barclays boosted their target price on Kimberly-Clark from $137.00 to $141.00 and gave the company an “equal weight” rating in a research report on Thursday, July 27th. TheStreet downgraded Kimberly-Clark from a “b” rating to a “c+” rating in a report on Tuesday, July 25th. Citigroup dropped their price objective on Kimberly-Clark from $130.00 to $126.00 in a report on Wednesday, July 26th. Finally, StockNews.com assumed coverage on shares of Kimberly-Clark in a report on Thursday, August 17th. They issued a “buy” rating on the stock. Two research analysts have rated the stock with a sell rating, seven have given a hold rating and two have issued a buy rating to the company. According to MarketBeat.com, the company presently has an average rating of “Hold” and an average target price of $135.33.

Kimberly-Clark Company Profile

Kimberly-Clark Corporation, together with its subsidiaries, manufactures and markets personal care and consumer tissue products worldwide. It operates through three segments: Personal Care, Consumer Tissue, and K-C Professional. The company's Personal Care segment offers disposable diapers, training and youth pants, swimpants, baby wipes, feminine and incontinence care products, reusable underwear, and other related products under the Huggies, Pull-Ups, Little Swimmers, GoodNites, DryNites, Sweety, Kotex, U by Kotex, Intimus, Thinx, Poise, Depend, Plenitud, Softex, and other brand names.